| |
|
|
|
Amneal Pharmaceuticals Inc  
|
|
3.95 -0.12 (-0.03%) |
11-30 15:59 |
|
Open: |
4.05 |
Pre close: |
4.07 |
Target:
|
5.53 
|
|
High: |
4.06 |
Low: |
3.9 |
Resistance:
|
4.73
5.25
|
|
Volume: |
947,721 |
Market Cap: |
583M |
Support:
|
3.90
3.24
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.04
|
MACD |
MACD(12,26):
|
-0.14 |
|
MA(20): |
4.23 |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
4.34 |
Stochastic Oscillator |
%K(14,3):
|
11.82 |
|
MA(250): |
4.27 |
%D(3): |
12.73 |
|
Average Volume(K) |
3-Month: |
117855
|
52-Week |
High:
|
5.79 |
|
10-Days: |
113413 |
Low: |
2.40 |
|
RSI |
RSI(14):
|
39.72 |
Change(%): |
-1.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.418 |
Return on Equity (ttm) |
2.8 |
Shares Out. (M) |
147.63 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
2.4 |
Shares Float (M) |
94.39 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.41 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
37.3 |
% Held by Institutions |
69.34 |
|
Forward EPS |
-2.740 |
Gross Profit (p.s.) |
3.366 |
Shares Short (K) |
6180 |
|
Book Value (p.s.) |
2.040 |
EBITDA (p.s.) |
2.568 |
P/E |
9.49 |
|
Sales Per Share |
12.735 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.94 |
|
Profit Margin |
3.30 |
Operating Cash Flow
(M) |
222.15 |
P/S |
0.31 |
|
Operating Margin |
7.94 |
Levered Free Cash Flow
(M) |
75.15 |
P/CF |
2.63 |
|
|
|
|
|
|
